We are live on ! Find out more
OPTN

OptiNose

Delisted

OPTN was delisted on the 20th of May, 2025.

84 hedge funds and large institutions have $114M invested in OptiNose in 2024 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 22 increasing their positions, 24 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

36% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 22

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

11% more funds holding

Funds holding: 7684 (+8)

0.35% more ownership

Funds ownership: 4.69%5.05% (+0.35%)

1% less capital invested

Capital invested by funds: $116M → $114M (-$1.35M)

8% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 24

Holders
84
Holders Change
+8
Holders Change %
+10.53%
% of All Funds
1.21%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
30
Increased
22
Reduced
24
Closed
22
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$243K +$260K +15,549 New
Renaissance Technologies
27
Renaissance Technologies
New York
$242K -$54.5K -3,253 -17%
BCM
28
Bridgeway Capital Management
Texas
$227K -$134K -8,000 -35%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$190K -$194K -11,597 -49%
Squarepoint
30
Squarepoint
New York
$178K +$122K +7,261 +174%
Verition Fund Management
31
Verition Fund Management
Connecticut
$167K +$180K +10,727 New
Qube Research & Technologies (QRT)
32
Qube Research & Technologies (QRT)
United Kingdom
$154K +$166K +9,903 New
PWM
33
Palumbo Wealth Management
New York
$141K +$18.4K +1,100 +14%
Morgan Stanley
34
Morgan Stanley
New York
$140K -$53.5K -3,192 -26%
CC
35
Centiva Capital
New York
$136K +$147K +8,747 New
BBHC
36
Brown Brothers Harriman & Co
New York
$104K
YIH
37
Y-Intercept (HK)
Hong Kong
$88.2K +$94.7K +5,654 New
XT
38
XTX Topco
Cayman Islands
$87.9K +$94.4K +5,634 New
PP
39
Paloma Partners
Connecticut
$86.5K +$92.9K +5,543 New
AGM
40
Alpine Global Management
New York
$85.1K +$91.3K +5,452 New
Assenagon Asset Management
41
Assenagon Asset Management
Luxembourg
$79.2K -$12.2K -727 -13%
Barclays
42
Barclays
United Kingdom
$74.1K -$33K -1,970 -29%
HF
43
HRT Financial
New York
$71K +$77.2K +4,610 New
Prudential Financial
44
Prudential Financial
New Jersey
$46.4K +$9.11K +544 +22%
Citadel Advisors
45
Citadel Advisors
Florida
$40.6K -$71.9K -4,295 -62%
Mirae Asset Global ETFs Holdings
46
Mirae Asset Global ETFs Holdings
Hong Kong
$38.9K +$41.8K +2,495 New
Charles Schwab
47
Charles Schwab
California
$37.6K -$186K -11,109 -82%
Invesco
48
Invesco
Georgia
$37.5K +$4.44K +265 +12%
Citigroup
49
Citigroup
New York
$33.6K +$24.7K +1,474 +217%
HSBC Holdings
50
HSBC Holdings
United Kingdom
$31.5K -$335 -20 -1%

OPTN Hedge Fund Activity: Q2 2024 in Review

84 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in OptiNose (OPTN) for Q2 2024, worth a combined $114M — down 1.2% from $116M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new OPTN positions and 22 closed out — a net gain of 8 holders — while 22 added to existing stakes and 24 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $12.2M. The largest seller was State Street, cutting an estimated $1.19M.

  • 84 institutional investors held OptiNose (OPTN) as of Q2 2024, up from 76 in Q1 2024.
  • Funds reported $114M of OptiNose stock for Q2 2024, down 1.2% quarter-over-quarter.
  • 30 funds opened new OptiNose positions in Q2 2024 and 22 closed out, a net change of +8 holders.
  • The largest OptiNose buyer in Q2 2024 was Nantahala Capital Management, an estimated $12.2M added.
  • The largest OptiNose seller in Q2 2024 was State Street, an estimated $1.19M sold.

Based on aggregated 13F filings for Q2 2024.